Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Molenaar

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|September 12, 2003
The 'state' of beta-adrenoceptorsPeter Molenaar
Multivariate Behavioral Research|February 17, 2016
EditorialPeter Molenaar
Multivariate Behavioral Research|February 17, 2016
Testing for Granger Causality in the Frequency Domain: A Phase Resampling MethodSiwei Liu, Peter Molenaar
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 27, 2004
Cardiovascular actions of human urotensin II--considerations for hypertensionFraser D Russell, Peter Molenaar
Trends in Pharmacological Sciences|June 7, 2005
Fundamental considerations of beta-adrenoceptor subtypes in human heart failurePeter Molenaar, William A Parsonage
Cardiovascular Research|August 13, 2004
Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heartFraser D Russell, Peter Molenaar
Pharmacology & Therapeutics|May 27, 2008
The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacologyAlberto J Kaumann, Peter Molenaar
British Journal of Pharmacology|January 25, 2006
Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wastingPeter Molenaar, Lu Chen, William A Parsonage
Handbook of Experimental Pharmacology|June 6, 2024
Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular DisordersYee Weng Wong, Haris Haqqani, Peter Molenaar
Cardiovascular Research|October 18, 2005
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heartPeter Molenaar, Torsten Christ, Ursula Ravens, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|September 12, 2003
The 'state' of beta-adrenoceptorsPeter Molenaar
Multivariate Behavioral Research|February 17, 2016
EditorialPeter Molenaar
Multivariate Behavioral Research|February 17, 2016
Testing for Granger Causality in the Frequency Domain: A Phase Resampling MethodSiwei Liu, Peter Molenaar
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 27, 2004
Cardiovascular actions of human urotensin II--considerations for hypertensionFraser D Russell, Peter Molenaar
Trends in Pharmacological Sciences|June 7, 2005
Fundamental considerations of beta-adrenoceptor subtypes in human heart failurePeter Molenaar, William A Parsonage
Cardiovascular Research|August 13, 2004
Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heartFraser D Russell, Peter Molenaar
Pharmacology & Therapeutics|May 27, 2008
The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacologyAlberto J Kaumann, Peter Molenaar
British Journal of Pharmacology|January 25, 2006
Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wastingPeter Molenaar, Lu Chen, William A Parsonage
Handbook of Experimental Pharmacology|June 6, 2024
Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular DisordersYee Weng Wong, Haris Haqqani, Peter Molenaar
Cardiovascular Research|October 18, 2005
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heartPeter Molenaar, Torsten Christ, Ursula Ravens, et al.
Pageof 8